Delivery Order N6264520D5002-HT940624F0085
Award Date
10/1/24
Potential Completion Date
10/1/24
Potential Value
$358K
Federal Agency
Defense Health Agency
Awardee
Cardinal Health 414, LLC
Ultimate Awardee
Cardinal Health, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, VA 23708, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the supply of radiopharmaceuticals to the Defense Health Agency (DHA). The $249,466.62 firm fixed-price purchase order was awarded to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract has an ultimate completion date of September 30, 2026. Cardinal Health 414 is a well-established provider of critical medical isotopes and radiopharmaceutical products used in nuclear medicine, oncology, and...
This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply of radiopharmaceuticals to the Defense Health Agency (DHA). The contract, which has a ceiling value of $19,596.65, is a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type and a performance period through September 30, 2024. Cardinal Health 414 is a leading provider of radiopharmaceuticals, radioactive isotopes, and specialty pharmaceuticals to various...
The Defense Health Agency awarded a firm fixed price delivery order contract worth up to $250,000.00 to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the provision of radiopharmaceuticals. The contract, which has no set-aside designation, will run through September 30, 2022. Cardinal Health 414 has previously held multiple indefinite delivery contracts to supply radiopharmaceuticals, radioactive isotopes, and other nuclear medicine products and services to the Department...
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, including radioactive isotopes, diagnostic imaging agents, nuclear medicine supplies, and specialty pharmaceuticals. The potential value of the contract is $145,418.67, with a completion date of September 30, 2021. Cardinal Health 414 has an established track record of delivering these...
This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc., to provide radiopharmaceuticals and related supplies to the Defense Health Agency, a component of the Department of Defense. The contract has a ceiling value of $53,310.11 and is a Blanket Purchase Agreement (BPA) call with firm-fixed pricing. The contract does not have a set-aside designation. Cardinal Health 414 has a history of delivering radiopharmaceuticals,...
This federal contract award was made by the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $537,527.30 firm fixed-price purchase order is for the supply of radiopharmaceuticals, including Tc-99m, I-123, I-131, In-111, Tl-201, F-18 FDG, and Ga-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has an ultimate completion date of September 30, 2027. This award is not set...
This federal contract award to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc., is for the supply of radiopharmaceuticals to various U.S. government health agencies, including the Department of Veterans Affairs (VA), Department of Defense (DOD), and National Institutes of Health (NIH). The award, valued at $136,249.45, is a delivery order under an Indefinite Delivery Vehicle (IDV) contract with the VA's Veterans Integrated Service Network 20....
This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA), Department of Defense (DoD), and National Institutes of Health (NIH). The contract has a total ceiling value of $702,128.87 and a performance period through March 31, 2024. The contract is a delivery order under an indefinite delivery vehicle (IDV) held by Cardinal Health 414 with the VA, allowing for...
This federal contract award to Cardinal Health 414, LLC Nphs Division, a subsidiary of Cardinal Health, Inc., is for the provision of various radiopharmaceuticals to the Defense Health Agency (DHA). The contract, with a ceiling value of $1,200,000.00, has an ultimate completion date of September 30, 2024. It is a Blanket Purchase Agreement (BPA) call, with a Firm Fixed Price (FFP) pricing type. The contract supports the DHA's mission to provide comprehensive healthcare services, including...
This federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., is for the delivery of radiopharmaceuticals to various federal healthcare agencies, including the Department of Veterans Affairs (VA), Department of Defense (DoD), and National Institutes of Health (NIH). The contract, valued at $382,756.63, is a firm fixed-price delivery order under an Indefinite Delivery Vehicle (IDV) with the VA. Cardinal Health 414 specializes in providing radiopharmaceuticals,...